Biotricity, Inc. (BTCY)

Biotricity Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Net Income	-14.93	-19.53	-30.22	-16.45	-11.32
Depreciation & Amortization	0.37	0.35	0.09	0	0
Share-Based Compensation	1.03	0.65	0.91	0.79	2.41
Other Operating Activities	6	4.12	12.96	3.62	0.8
Operating Cash Flow	-6.69	-13.55	-15.16	-11.08	-7.86
Capital Expenditures	0	0	-0.03	0	0
Investing Cash Flow	0	0	-0.03	0	0
Share Issuance / Repurchase	0.12	0	14.8	0	0.03
Debt Issued / Paid	3.82	3.83	10.6	12.54	1.2
Other Financing Activities	2.81	-1.83	-0.22	-0.34	7.65
Financing Cash Flow	6.74	2	25.17	12.2	8.88
Exchange Rate Effect	0.17	0.05	-0.11	0.13	-0.13
Net Cash Flow	0.05	-11.55	9.98	1.12	1.02
Free Cash Flow	-6.69	-13.55	-15.19	-11.08	-7.86
Free Cash Flow Margin	-55.49%	-140.55%	-198.60%	-327.37%	-554.61%
Free Cash Flow Per Share	-0.74	-1.56	-2.01	-1.77	-1.31

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).